Skip to content

Hypertension and Diabetes Mellitus Community Management Center(HAD-COME) Project

Establishment of Hypertension and Diabetes Mellitus Community Management Center(HAD-COME) Project

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04229628
Enrollment
100000
Registered
2020-01-18
Start date
2020-01-01
Completion date
2023-12-31
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Hypertension

Brief summary

To develop and implement quality improvement programs for the treatment and management of hypertension and diabetes,and preventing and controlling hypertension and diabetes-related diseases in Chinese community. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of hypertension and diabetes in Chinese community.

Detailed description

The aim of this project was to improving care for hypertension and diabetes mellitus in Chinese community. Study population including subjects who are hypertension and/or diabetes mellitus, of any race or ethnicity, any age.

Interventions

No special intervention

Sponsors

Guangdong Provincial People's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* In accordance with the diagnosis of essential hypertension; * In accordance with the diagnosis of type 2 diabetes mellitus.

Exclusion criteria

* Non-type 2 diabetes patients * Secondary hypertension * Non-hypertensive patients * Type 1 diabetes or other types of diabetes

Design outcomes

Primary

MeasureTime frameDescription
Proportion of community hypertension patients receiving treatment as Chinese guideline recommendedat the time of enrollmentProportion of community hypertension patients receiving treatment as Chinese guideline recommended at the time of enrollment
Proportion of community diabetes mellitus patients receiving treatment as Chinese guideline recommendedat the time of enrollmentProportion of community diabetes mellitus patients receiving treatment as Chinese guideline recommended at the time of enrollment

Countries

China

Contacts

Primary ContactFeng Ying-qing, PhD
651792209@qq.com+862083827812

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026